Trial Profile
A phase 1, first-in-human clinical trial of DS-1211 in healthy volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 08 Sep 2017
Price :
$35
*
At a glance
- Drugs DS-1211 (Primary)
- Indications Calcinosis
- Focus Adverse reactions; First in man
- Sponsors Daiichi Sankyo Company
- 08 Sep 2017 New trial record
- 06 Sep 2017 According to a Daiichi Sankyo Company media release, first subject has been enrolled in this trial.